Corient Private Wealth LP Invests $17.06 Million in Avantor, Inc. $AVTR

Corient Private Wealth LP acquired a new position in shares of Avantor, Inc. (NYSE:AVTR) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 1,722,983 shares of the company’s stock, valued at approximately $17,058,000. Corient Private Wealth LP owned approximately 0.25% of Avantor as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently bought and sold shares of AVTR. Bank of America Corp DE acquired a new position in Avantor during the 2nd quarter worth approximately $108,795,000. Freestone Grove Partners LP acquired a new position in Avantor during the second quarter worth $56,577,000. Man Group plc bought a new position in Avantor in the second quarter valued at $9,806,000. Jupiter Topco LLC acquired a new stake in Avantor in the 2nd quarter valued at $3,047,000. Finally, ADAR1 Capital Management LLC acquired a new stake in Avantor in the 2nd quarter valued at $1,287,000. Institutional investors own 95.08% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. Sanford C. Bernstein assumed coverage on shares of Avantor in a research note on Friday, June 26th. They set a “market perform” rating and a $10.50 price objective for the company. Barclays upped their target price on Avantor from $7.00 to $8.00 and gave the stock an “underweight” rating in a report on Wednesday, June 24th. Wolfe Research raised Avantor from a “strong sell” rating to a “hold” rating in a research report on Thursday, July 30th. Stifel Nicolaus upped their price objective on Avantor from $8.00 to $15.00 and gave the stock a “hold” rating in a research note on Thursday, July 30th. Finally, Wells Fargo & Company boosted their target price on shares of Avantor from $14.00 to $16.00 and gave the stock an “overweight” rating in a report on Thursday, July 30th. Two investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $12.00.

Avantor Stock Down 0.1%

AVTR stock opened at $14.60 on Friday. Avantor, Inc. has a 1-year low of $7.26 and a 1-year high of $15.93. The business’s 50 day simple moving average is $12.12 and its 200 day simple moving average is $9.77. The company has a current ratio of 1.78, a quick ratio of 1.18 and a debt-to-equity ratio of 0.65. The firm has a market capitalization of $9.87 billion, a PE ratio of -17.38, a PEG ratio of 11.03 and a beta of 0.89.

Avantor (NYSE:AVTR) last announced its quarterly earnings results on Wednesday, July 29th. The company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.02. Avantor had a positive return on equity of 9.92% and a negative net margin of 8.81%.The business had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.61 billion. During the same quarter last year, the firm posted $0.24 EPS. The company’s quarterly revenue was up .5% on a year-over-year basis. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. As a group, research analysts anticipate that Avantor, Inc. will post 0.81 EPS for the current year.

About Avantor

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.